• Investor Relations
  • About us
  • Contact us
  • Careers
    • Life Science Field Support Technician – United States
    • Field Application Scientist – United States
    • Field Application Scientist, APAC
    • Field Application Scientist – DACH
  • Support
  • German
  • French
  • Japanese
  • Products
    • NucleoCounter® NC-3000™
    • NucleoCounter® NC-202™
    • NucleoCounter® NC-200™
    • NucleoCounter® SP-100™
    • NucleoCounter® YC-100™
    • Xcyto®
    • Via1-Cassette & Via2-Cassette
    • NucleoView™ Software
    • Consumables
    • Accessories
  • Solutions
    • Cell Therapeutic Applications
    • Stem Cell Research
    • Cancer Cell Research
    • Bioprocessing
    • Toxicology
    • Cell Biology Research
    • Sperm Cell Counting
    • Yeast Cell Counting
  • Technical Resources
    • Application Notes
    • Articles
    • Assays
    • Cell types
    • Customer projects
    • Posters
    • Publications
    • Testimonials
    • Videos
    • Webinars
Webshop
  • Products
    • NucleoCounter® NC-3000™
    • NucleoCounter® NC-250
    • NucleoCounter® NC-200™
    • NucleoCounter® NC-100
    • NucleoCounter® SP-100
    • NucleoCounter® YC-100
    • NucleoCounter® SCC-100
    • NucleoCounter® SCC-400
  • Applications
    • Cell counting in cell therapeutic applications
    • Stem Cells Counting
    • Bioprocessing
    • Toxicology
    • Research
    • Cancer Cell Counting
    • Sperm Cell Counting
    • Yeast Cell Counting
    • Somatic Cell Counting
  • Resources
  • Investor Relations
  • About us
  • Contact
  • Careers
    • Senior Sales Representatives USA
    • Field Application Scientist USA
    • Vertriebsmitarbeiter im Außendienst (m/w) (Germany)
    • Field Application Scientist, Germany
    • Sales Manager, United Kingdom
    • Chinese speaking Field Application Scientist, Denmark
  • Webshop

COVID-19

The outbreak of Coronavirus has spread to all of the world, and continues to be serious matter in most countries still fighting against this pandemic. At ChemoMetec, we are closely monitoring the situation, and we support and comply with the guidelines issued by local and global authorities.

We are fully focused on ensuring the best possible services to our customers, including delivering our products where possible. We continue a close dialogue with our customers and partners. At the same time, we take all necessary measures to ensure the safety and health of our employees, customers and partners.

At our headquarters, production and services are almost back to normal, albeit under new and strict safety procedures and hygiene measures. Our employees in EU, the USA and rest of the world work mainly from home to avoid further spread of the virus, but we maintain our production and logistics capabilities at 100%. We aim to keep our stakeholders informed of any changes to our business and operating practices. You can still contact us through our website and through our customer service team in each country.

For further information on how we support our customers during the COVID-19 pandemic, please read more.

We would like to thank you in advance for your understanding and flexibility during these challenging times. Stay safe and take care of yourself and each other.

Kindest regards,
The ChemoMetec management team.

Instruments

Xcyto® 5
NucleoCounter® NC-3000™ NucleoCounter® NC-202™ NucleoCounter® NC-200™ NucleoCounter® SP-100™ NucleoCounter® YC-100™

Sales

Request Demo
Request Quote

WebShop

Buy reagents and more

Contact

Contact
Find distributors
Register NucleoCounter®

Support/Help

Science Support Center

Follow us

  • FacebookFacebook
  • LinkedInLinkedIn
  • TwitterTwitter
  • YouTubeYouTube

Terms & Conditions

Sales Terms and Conditions - Europe and ROW

Sales Terms and Conditions - USA and Canada

ChemoMetec A/S © 1997-2020 All Rights Reserved
Gydevang 43, DK-3450 Allerod, Denmark | Tel: +45 48131020 | Fax: +45 48131021 | mail: contact@chemometec.com
CVR: 19828131 | LEI: 213800533NBKECGONO68
www.chemometec.com| www.chemometec.de| www.chemometec.fr EXTRANET
This site uses cookies. By continued use of our site, you accept our websites use of cookies. Find out more.